Abstract
Myelodysplastic syndrome (MDS) is composed of a diverse spectrum of hematopoietic stem cell malignancies characterized by ineffective blood cell production. Many MDS patients are dependent on red blood cell (RBC) transfusions for symptomatic management of refractory anemia. Iron overload ensues when the iron acquired from transfused RBCs exceeds body storage capacity, thereby raising the risk for end organ damage. This is of greatest concern in patients with lower-risk MDS whose expected survival is measured in years. Transfusion dependence is associated with shorter survival and an increased risk for progression to acute myeloid leukemia (AML) in transfusion-dependent patients. Application of recent advances in the treatment of MDS can reduce or eliminate the need for transfusions, thus minimizing the risk of iron overload. Case control studies, prospective surveys, and phase II studies indicate that iron chelation therapy reduces iron load as measured by changes in serum ferritin and may prolong overall survival. Iron chelation strategies include oral agents such as deferasirox (Exjade, Novartis Pharmaceuticals Corp, East Hanover, NJ), deferiprone (Ferriprox, Apotex Europe BV, Leiden, the Netherlands) and, for those patients ...Continue Reading
References
May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lewis R SilvermanJames F Holland
Sep 28, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luca MalcovatiMario Cazzola
Mar 17, 2006·Hemoglobin·Jaroslav Cermák
Oct 6, 2006·The New England Journal of Medicine·Alan ListUNKNOWN Myelodysplastic Syndrome-003 Study Investigators
Jan 20, 2007·Blood·Philippe ArmandJoseph H Antin
Mar 30, 2007·European Journal of Haematology·Masaaki TakatokuUNKNOWN Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes
Apr 4, 2007·PharmacoEconomics·Thomas E DeleaThomas D Coates
Sep 26, 2007·Blood·Azra RazaAlan F List
Dec 6, 2007·Leukemia Research·Luca Malcovati
Dec 6, 2007·Leukemia Research·Heather A Leitch
Jan 12, 2008·Cancer·Elias JabbourAli Taher
Feb 26, 2008·Leukemia & Lymphoma·Sameer MaheshAmit Verma
Apr 15, 2008·Leukemia Research·Richard A WellsAlan Tinmouth
Apr 30, 2008·Blood·Dana E RollisonAlan F List
Sep 2, 2008·Annals of Hematology·Georgia MetzgerothJan Hastka
Oct 18, 2008·Cancer Control : Journal of the Moffitt Cancer Center·Ghulam J Mufti, Tara L Chen
Oct 30, 2008·Journal of the National Cancer Institute·Mikkael A SekeresJaroslaw P Maciejewski
Dec 17, 2008·Blood Reviews·John C Wood
Dec 17, 2008·Blood Reviews·François Dreyfus
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roger M LyonsC L Beach
Nov 6, 2009·The New England Journal of Medicine·Ayalew Tefferi, James W Vardiman